Principles and current strategies for targeting autophagy for cancer treatment
- PMID: 21325294
- PMCID: PMC3075808
- DOI: 10.1158/1078-0432.CCR-10-2634
Principles and current strategies for targeting autophagy for cancer treatment
Abstract
Autophagy is an evolutionarily conserved, intracellular self-defense mechanism in which organelles and proteins are sequestered into autophagic vesicles that are subsequently degraded through fusion with lysosomes. Cells, thereby, prevent the toxic accumulation of damaged or unnecessary components, but also recycle these components to sustain metabolic homoeostasis. Heightened autophagy is a mechanism of resistance for cancer cells faced with metabolic and therapeutic stress, revealing opportunities for exploitation as a therapeutic target in cancer. We summarize recent developments in the field of autophagy and cancer and build upon the results presented at the Cancer Therapy Evaluation Program (CTEP) Early Drug Development meeting in March 2010. Herein, we describe our current understanding of the core components of the autophagy machinery and the functional relevance of autophagy within the tumor microenvironment, and we outline how this knowledge has informed preclinical investigations combining the autophagy inhibitor hydroxychloroquine (HCQ) with chemotherapy, targeted therapy, and immunotherapy. Finally, we describe ongoing clinical trials involving HCQ as a first generation autophagy inhibitor, as well as strategies for the development of novel, more potent, and specific inhibitors of autophagy.
©2011 AACR.
Figures
Similar articles
-
Targeting Autophagy in Cancer: Update on Clinical Trials and Novel Inhibitors.Int J Mol Sci. 2017 Jun 16;18(6):1279. doi: 10.3390/ijms18061279. Int J Mol Sci. 2017. PMID: 28621712 Free PMC article. Review.
-
The role of autophagy in cancer: therapeutic implications.Mol Cancer Ther. 2011 Sep;10(9):1533-41. doi: 10.1158/1535-7163.MCT-11-0047. Epub 2011 Aug 30. Mol Cancer Ther. 2011. PMID: 21878654 Free PMC article. Review.
-
Induction of autophagy is an early response to gefitinib and a potential therapeutic target in breast cancer.PLoS One. 2013 Oct 11;8(10):e76503. doi: 10.1371/journal.pone.0076503. eCollection 2013. PLoS One. 2013. PMID: 24146879 Free PMC article.
-
Combined MTOR and autophagy inhibition: phase I trial of hydroxychloroquine and temsirolimus in patients with advanced solid tumors and melanoma.Autophagy. 2014 Aug;10(8):1391-402. doi: 10.4161/auto.29119. Epub 2014 May 20. Autophagy. 2014. PMID: 24991838 Free PMC article. Clinical Trial.
-
Recent advances in targeting autophagy in cancer.Trends Pharmacol Sci. 2023 May;44(5):290-302. doi: 10.1016/j.tips.2023.02.003. Epub 2023 Mar 15. Trends Pharmacol Sci. 2023. PMID: 36931971 Free PMC article. Review.
Cited by
-
BECN1 mRNA expression in breast cancer tissue; significant correlation to tumor grade.Mol Genet Genomics. 2024 May 24;299(1):56. doi: 10.1007/s00438-024-02145-2. Mol Genet Genomics. 2024. PMID: 38787424 Free PMC article.
-
Computational Design of Novel Cyclic Peptides Endowed with Autophagy-Inhibiting Activity on Cancer Cell Lines.Int J Mol Sci. 2024 Apr 24;25(9):4622. doi: 10.3390/ijms25094622. Int J Mol Sci. 2024. PMID: 38731842 Free PMC article.
-
Phenformin activates ER stress to promote autophagic cell death via NIBAN1 and DDIT4 in oral squamous cell carcinoma independent of AMPK.Int J Oral Sci. 2024 May 8;16(1):35. doi: 10.1038/s41368-024-00297-w. Int J Oral Sci. 2024. PMID: 38719825 Free PMC article.
-
Advances in research on autophagy mechanisms in resistance to endometrial cancer treatment.Front Oncol. 2024 Mar 27;14:1364070. doi: 10.3389/fonc.2024.1364070. eCollection 2024. Front Oncol. 2024. PMID: 38601753 Free PMC article. Review.
-
Targeting the RAS/RAF/MAPK pathway for cancer therapy: from mechanism to clinical studies.Signal Transduct Target Ther. 2023 Dec 18;8(1):455. doi: 10.1038/s41392-023-01705-z. Signal Transduct Target Ther. 2023. PMID: 38105263 Free PMC article. Review.
References
-
- Kuma A, Mizushima N. Physiological role of autophagy as an intracellular recycling system: with an emphasis on nutrient metabolism. Semin Cell Dev Biol. 21:683–90. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
- 1K23CA120862-01A2/CA/NCI NIH HHS/United States
- RC1 CA147961/CA/NCI NIH HHS/United States
- CA111456/CA/NCI NIH HHS/United States
- R01CA130893/CA/NCI NIH HHS/United States
- K23 CA120862/CA/NCI NIH HHS/United States
- RC1CA147961/CA/NCI NIH HHS/United States
- P50 CA097257/CA/NCI NIH HHS/United States
- RC1 CA147961-02/CA/NCI NIH HHS/United States
- R01 CA130893-04/CA/NCI NIH HHS/United States
- CA83817/CA/NCI NIH HHS/United States
- R37 CA053370/CA/NCI NIH HHS/United States
- R01 CA083817/CA/NCI NIH HHS/United States
- R37 CA053370-19/CA/NCI NIH HHS/United States
- U01 CA132194/CA/NCI NIH HHS/United States
- P50CA097257/CA/NCI NIH HHS/United States
- R37CA53370/CA/NCI NIH HHS/United States
- R01 CA130893/CA/NCI NIH HHS/United States
- R01 CA111456/CA/NCI NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources